ARTICLE | Clinical News
GynTect regulatory update
September 28, 2015 7:00 AM UTC
oncgnostics received CE Mark approval for GynTect to detect cervical precancerous lesions and cancer. The epigenetic test is used when patients are diagnosed with an abnormal Pap smear or a high-risk ...